On December 20th, a molecular biologist at the University of Central Florida said that an acre of genetically modified tobacco plants could produce enough anthrax vaccines to safely and cheaply inoculate for all Americans. Professor Henry Daniell said that his method has been used in other vaccines and scarce medicines to eliminate the scarcity of drugs, reduce costs by 80 cents, and control the introduction of pollution, which is the production of vaccines using conventional fermentation methods. Frequently encountered problems. Professor Daniel said that he chose tobacco to produce vaccines and other medicines because tobacco is a perennial, highly productive species that can produce 1 million seeds per plant. He said that unlike corn and other edible plants, a genetically engineered tobacco can no longer enter food supply channels. "This is a revolutionary concept," said Professor Daniel, who spent 20 years studying the possibility of producing therapeutic drugs through the production of genetically modified crops. "This is a new era of technology." Professor Daniel said that in order to make an anthrax vaccine, he injected the vaccine gene into the chloroplast genome of tobacco cells. Professor Daniel said that in recent tests conducted by the National Institute of Health, mice that had been injected with vaccines for tobacco production survived anthrax attacks that were 15 times more likely than terrorist anthrax attacks. This research, which was partially funded by the National Health Agency and the U.S. Department of Agriculture, was published in the December issue of the Journal of Infection and Immunization as a special report published by the American Society of Microbiology. Professor Daniel said that his vaccine is naturally immune to anthrax virus and that the anthrax virus has contaminated military vaccines produced by traditional fermentation methods, resulting in a decline in the immunity of some army personnel. In addition to the anthrax vaccine, Professor Daniel said that he is using tobacco-derived vaccines for research on type 1 diabetes, hepatitis C, cholera and plague. He said that type 1 diabetes has been controlled and that mice that injected his tobacco-produced insulin have improved within eight weeks. He said that he can reduce the cost of hepatitis C treatment from $40,000 to $20 through tobacco-based drugs. He said that the exact number of anthrax vaccines that can be saved cannot be determined at this time, because the cost cannot be obtained from the military at present. The next step in the anthrax virus is to experiment on humans and specific levels of immunity will be detected. Professor Daniel said tobacco-related drugs will be available in the next three to five years.
Earhook Hearing Aid
Earhook Hearing Aid
Shenzhen Sunshine Technology Co.,Ltd , https://www.shenzhenyatwin.com